Abdominal positron-emission tomography lesions with increased standardized uptake values correlate with intraoperative findings

American Journal of Surgery

Volumn 191, Issue 1, 2006, Pages 39-44

  Horst, Sara ^a   Kocak, Ergun ^a   Young, Donn ^a   Mantil, Joseph ^b   Martin Jr , Edward W ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b KETTERING MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; FDG PET scan; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DIGESTIVE SYSTEM INJURY; DRUG UPTAKE; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LAPAROTOMY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STANDARDIZATION; STATISTICAL ANALYSIS;

ABDOMEN; ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE;

EID: 29944441838     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.10.001     Document Type: Article

References (38)

1. R.T. Greenlee, M.B. Hill-Harmon, T. Murray Cancer Statistics, 2001 Ca Cancer J Clin 51 2001 1 36
2. D. Obrand, P. Gordon Incidence and pattern of recurrence following curative resection of colon cancer Dis Colon Rectum 40 1997 15 24
3. R.W. Beart Colon and rectum M.D. Abeloff J.Q. Armitage A.S. Lichter Clinical Oncology 1995 Churchill Livingstone New York 1267 1286
4. H.J. Wanebo, Q.D. Chu, M.P. Vezeridis Patient selection for hepatic resection of colorectal metastases Arch Surg 131 1996 322 329
5. D.A. August, R.T. Ottow, P.H. Sugarbaker Clinical perspective on human colorectal cancer metastasis Cancer Metastasis Rev 3 1984 303 324
6. G. Steele Jr, R. Bleday, R.J. Mayer A prospective evaluation of hepatic resection for colorectal carcinoma metastases to liver gastrointestinal tumor study group protocol 6584 J Clin Oncol 9 1991 1105 1112
7. K.S. Hughes, R. Simon, S. Songhorabodi Resection of the liver for colorectal carcinoma metastatic to the liver a multi-institutional study of indications for resection Surgery 100 1986 278 284
8. B.A. Ward, D.L. Miller, J.A. Frank Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases correlation with surgical findings Surgery 105 1989 180 187
9. T.G. John, J.D. Greig, J.L. Crosbie Superior imaging of liver tumors with laparoscopy and laparoscopic ultrasound Ann Surg 220 1994 711 719
10. T.H.A. Arulampalam, D.C. Costa, P.J. Bomanji, P.J. Ell The clinical application of positron emission tomography to colorectal cancer management Q J Nucl Med 45 2001 215 230
11. M.M. Graham, L.M. Peterson, R.M. Hayward Comparison of simplified quantitative analyses of FDG uptake Nucl Med Biol 27 2000 647 655
12. V. Ahuja, R.E. Coleman, J. Herndon, E.F. Patz The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma Cancer 83 1998 918 924
13. J.F. Vansteenkiste, S.G. Stroobants, P.J. Dupont Prognostic importance of the standardized uptake value on 18F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer an analysis of 125 cases J Clin Oncol 17 1999 3201 3206
14. R.S. Brown, J.Y. Leung, P.V. Kison Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer J Nucl Med 40 1999 556 565
15. H. Minn, M. Lapela, P.J. Klemi Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer J Nucl Med 38 1997 1907 1911
16. A. Allal, P. Dulguerov, M. Allaoua Standardized uptake value of 2-[18F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy J Clin Oncol 20 2002 1398 1404
17. J. Vitola, D. Delbeke Positron emission tomography for evaluation of colorectal carcinoma Semin Roentgenol 37 2002 118 128
18. M.H. Whiteford, H.M. Whiteford, L.F. Yee Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum Dis Colon Rectum 43 2000 759 770
19. L. Staib, H. Schirrmeister, S.N. Reske, H.G. Beger Is (18)Fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 180 2000 1 5
20. 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases Am J Surg 178 1999 282 287
21. P.E. Valk, E. Abella-Columna, M.K. Haseman Whole-body PET imaging with [18F]Fluorodeoxyglucose in management of recurrent colocrectal cancer Arch Surg 134 1999 503 511
22. P. Flamen, O.S. Hoekstra, F. Homans Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer the utility of positron emission tomography (PET) Eur J Cancer 37 2001 862 869
23. M. Imbriaco, T. Akhurst, S. Hilton Whole-body FDG-PET in patients with recurrent colorectal carcinoma a comparative study with CT Clin Positron Imaging 3 2000 107 114
24. D.T. Lai, M. Fulham, M.S. Stephen The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver Arch Surg 31 1996 703 707
25. T.J. Ruers, B.S. Langenhoff, N. Neeleman Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases a prospective study J Clin Oncol 20 2002 388 395
26. R.H. Huebner, K.C. Park, J.E. Shepherd A meta-Analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer J Nucl Med 41 2000 1177 1189
27. V. Kalff, R.J. Hicks, R.E. Ware The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer a prospective study J Nucl Med 43 2002 492 499
28. S.M. Strasberg, F. Dehdashti, B.A. Siegel Survival of patients evaluated by FDG-PET before hepatic resection of metastatic colorectal carcinoma a prospective database study Ann Surg 233 2001 293 299
29. S.K. Libutti, H.R. Alexander Jr, P. Choyke A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels Ann Surg Oncol 8 2001 779 786
30. K. Johnson, A. Bakhsh, D. Young Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer Dis Colon Rectum 44 2001 354 357
31. M.J. O'Doherty, P.K. Marsden Being equipped for clinical PET Lancet 356 2000 1701 1703
32. K.H. Pham, M.R. Ramaswamy, R.A. Hawkins Advances in positron emission tomography imaging for the GI tract Gastrointest Endosc 55 2002 S53 S63
33. E.M. Rohren, E.K. Paulson, R. Hagge The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer Clin Nucl Med 27 2002 550 555
34. H.S. Huang Anatomy of SUV Nucl Med Biol 27 2000 643 646
35. M.M. Graham, L.M. Peterson, R.M. Hayward Comparison of simplified quantitative analyses of FDG uptake Nucl Med Biol 27 2000 647 655
36. W.A. Weber, M. Schwaiger, N. Avril Quantitative assessment of tumor metabolism using FDG-PET imaging Nucl Med Biol 27 2000 683 687
37. Y. Sugawara, K.R. Zasadny, A.W. Neuhoff Reevaluation of the standardized uptake value for FDG variations with body weight and methods for correction Radiology 213 1999 521 525
38. Y. Nakamoto, K.R. Zasadny, H. Minn, R.L. Wahl Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose Mol Imaging Biol 4 2002 171 178